Pioglitazone HCL and Metformin HCL 15 mg/1

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve insulin sensitivity and glucose control.

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets are typically used to help manage type 2 diabetes. Pioglitazone works by making your body more sensitive to insulin, while Metformin helps lower glucose production in the liver. Together, they assist in maintaining stable blood sugar levels. This combination is often prescribed for individuals who require dual-action therapy to achieve better glycemic control.

Common effects of Pioglitazone HCL and Metformin HCL 15 mg/1 tablets may include mild stomach upset, weight gain, and occasional dizziness. Some users might experience fluid retention or low blood sugar, especially when starting the medication or adjusting dosages. It's important to monitor for any persistent or severe symptoms and consult a healthcare provider if needed.

Handle Pioglitazone HCL and Metformin HCL 15 mg/1 tablets with care, especially if you have a history of liver or kidney issues. Avoid alcohol while taking this medication, as it can increase the risk of side effects. Always follow the prescribed dosage and storage instructions to ensure safety and effectiveness.

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets may interact with certain medications, including other diabetes drugs, steroids, and some antibiotics. Alcohol and certain heart or blood pressure medications can also affect how this combination works. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.